Because this is really a non-event. 1) The targets for instance $35 by ML/BAC has ZERO in it for lawsuit proceeds. Its all upside to the $35 target which is $10 higher than current price WITHOUT lawsuit proceeds. The base business is going that well.
2) 75%-80% of the DRAM business is already under license so this is not as important as the wireless case. Most of the DRAM business is not affected.
3) No lawsuit proceeds are included in company guidance or analyst estimates.
4) This is the same judge that ruled no infringement in the Wireless Case. He was overturned by the full ITC in that case and will be in this one IMO. In retrospect this should have been expected - as if he changed this ruling based upon the ITC overturn in the wireless case - he would be admitting his ruling in the wireless case was wrong. It was - but he can't say that and put it on a silver platter.
Buy all you can. This stock will be much higher by yr end IMO
Also, with company's excellent June quarter results and September quarter outlook, and with the general market kept making new highs, over the past month, the stock actually declined nearly 20%. Apparently, the bad news was expected and factored into the stock price during the period.
A typical "Sell on the rumor, buy on the news".
In the near future, with a general market correction under way, TSRA will probably just follow the direction of the market. So there would be chances to add more shares into your positions down the road.